Gabriele M Cerrone bought $42k of TLSA
director, owner at Tiziana Life Sciences Ltd. 42,357 shares at an average of $0.99, traded Jul 21, 2026, filed Aug 7, 2026.
Score components
- +15RoleDirector
- +6Trade size$42k at market
- -5Relative to holdingsUnder 1% of holdings (0.1%)
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- +10Track recordMedian 6-month excess return +68% over 5 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-26-086697, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | POpen-market purchase COMMON STOCKindirect: Via Panetta Partners Limited | +42,357 | $0.99 | $42k | 44,814,587 | Aug 7, 2026 |
Related signals
Other insiders at Tiziana Life Sciences Ltd and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | TLSAbuy Tiziana Life Sciences Ltd | Gabriele M Cerrone director, owner | $17k 15,000 shares | +0% | |
| 55Moderate | Tiziana Life Sciences Ltd | Ivor Elrifi Chief Executive Officer | $319k 321,423 shares | +7% | |
| 56Moderate | Tiziana Life Sciences Ltd | Ivor Elrifi Chief Executive Officer | $667k 667,000 shares | +18% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.